The reported results are promising: Over 80% relative bioavailability Around 160 higher bioavailability vs oral tablets Sustained drug levels for ~1 week (once-weekly dosing potential) Additionally, the microneedle patches are stable at room temperature, eliminating the need for cold storage, unlike semaglutide injections
It has had very good weight loss, around 27% of total body mass, but the drop-out rate in the trial is 20% due to side effects, he says
Research found that patients prescribed tirzepatide who actively participated in Voys science-backed programme achieved an average weight loss of 22% after 11 months
GLP-1 receptor activation suppresses appetite, slows gastric emptying, and promotes insulin secretion in a glucose-dependent manner
Sobo Retatrutide Research Retatrutide Weight Loss Medication Shows Promise Comparative Efficacy (NNT) Efficacy of Tirzepatide, Retatrutide, and Semaglutide for Weight Loss Read more our posts